Oxonica's Optisol™ UV Absorber is Now Available to Buy at Boots' Stores Nationwide26th April 2005 Oxonica Ltd, a leading European technology company, has patented a revolutionary new UV filter called Optisol™. As of this month, Optisol™ is available on shelves as an active component of Boots' new Soltan Facial Sun Defence Cream. Optisol™ offers several major benefits over existing filters. In addition to protecting against UVB, the traditional focus of sun protection, Optisol™ offers enhanced protection against UVA light. It is now believed that UVA light is also responsible for skin damage and sunscreens sold in the UK have a star rating, developed by Boots PLC, to indicate the amount of UVA protection offered. Test data has shown that sunscreens formulated with Optisol™ can provide enhanced protection against both UVB and UVA. Optisol™ is a milder, longer lasting and innovative new form of titanium dioxide, a commonly used ingredient in sunscreens which acts to absorb UV light. A tiny amount of manganese is incorporated within the titanium dioxide, adding major benefits; the manganese absorbs extra UVA giving a higher level of protection and also acts to stop the formation of free radicals in the titanium dioxide. These effects give enhanced performance which is extremely photostable ensuring that the product's ability to protect isn't broken down by the sun. Further benefits are seen in a broader cosmetic context. Anti-oxidants such as vitamin C are commonly added to cosmetic products to scavenge free radicals and promote healthy skin. However, the anti-oxidants themselves can be degraded by UV. Optisol™ provides additional performance benefits by acting to protect vitamins and plant extracts from UV allowing these cosmetic anti-oxidants to retain efficacy for longer. In this way, Optisol™ further helps to prevent cell damage and premature skin ageing. Optisol™ also enhances the cosmetic performance of formulated products, with users reporting an immediate improvement in skin tone and radiance. Mike Brown, Boots Suncare Scientific Adviser, who played a central
role in the creation of the new range of Soltan Facial sun protection
said: David Browning, Business Director, Oxonica Healthcare said: Oxonica is also in discussions with other major cosmetic companies regarding inclusion of Optisol™ in their sun care and cosmetic ranges. The Company is looking to build relations worldwide and has recently signed their first distribution agreement with Hanjoo C&C Co. Ltd, to further market Optisol™ UV Absorber in South Korea. NOTES TO EDITORSAbout Oxonica - www.oxonica.com Oxonica Limited is a leading European technology group, with products already launched into the global market. The company was spun-out in 1999 from the University of Oxford and is based in Oxford, England. Oxonica currently employs 30 professional staff and is led by a strong and commercially experienced management team. Oxonica's mission is to develop commercial solutions from technology. It owns a diverse portfolio of demand driven products that offer substantial benefits to the target markets of environmental, healthcare and materials. Lead products include:
Oxonica is also active in searching for the next generation of products and is already engaged in developing transformational detection technologies which will enable a new generation of diagnostic products for the clinical diagnostic and life science markets. In addition, the company is developing other UV absorber technologies into polymer systems and coatings, based on similar technologies to that used in Optisol™. Optisol™ and Envirox™ are trademarks of Oxonica Ltd. For further information please contact: Oxonica Buchanan Communications |